The Division of Nephrology at Vanderbilt University Medical Center has a long and notable history of the study, treatment, causes and potential therapies of kidney disease.
With leading researchers, clinicians, and instructors working in state-of-the-art facilities our contributions are significant and validated through the many publications, honors, and grant funding received as we help to advance cures for kidney disease through scientific discoveries, cutting-edge treatments, and renal transplants.
Vanderbilt Nephrology is ranked as one of the top Nephrology Divisions by U.S. News and World Reports.
Our Clinical Specialties Include:
● Dialysis for Kidney Failure
(Vanderbilt Dialysis Clinic, East Dialysis Clinic)
● Pathophysiology of Renal Injury
● End Stage Renal Disease
● Nephrolithiasis (kidney stones)|
Our Education Opportunities Include:
● Clinical Fellowship
● Research Fellowship
● Advanced Fellowship in Renal Transplantation
● Over 340 educational conferences offered yearly
● Mouse Kidney Injury Workshop
● Summer Research Training Program
Our Research Facilities Include:
Inspire interest in the prevention of disease, promote human health, cultivate biomedical discovery, provide compassionate care, and educate tomorrow's leaders.
Provide excellence in patient care, train physicians and researchers, lead in scientific research and discoveries in understanding and treating acute and chronic renal disease, and promote collaborations within the scientific domain.
Our Division Leadership:
Raymond Harris, MD is the Chief of the Division of Nephrology, the Ann and Roscoe Robinson Professor of Medicine, Division of Nephrology in the Department of Medicine, Vanderbilt University Medical Center, and the Director of the Vanderbilt Center of Kidney Disease. Dr. Harris’ lab focuses on the understanding of mechanisms and developing potential therapeutic interventions for acute and chronic renal injury and also the role of growth factors, especially the EGF family of growth factors in mediating the recovery from acute kidney injury and potential mediators of progressive fibrosis in chronic kidney disease. His research interests also focus on progressive kidney injury especially in diabetic nephropathy.
T. Alp Ikizler, MD is the Associate Chief of the Division of Nephrology, the Catherine Mclaughlin Hakim Chair in Vascular Biology, Professor of Medicine, Division of Nephrology in the Department of Medicine, Vanderbilt University Medical Center. Dr. Ikizler’s main research interest is focused on the metabolic and nutritional aspects of patients with kidney disease, especially ones with acute kidney injury and advanced kidney disease.
Over 20 million Americans have kidney disease, and the vast majority is not aware of their condition. This fund supports world-renown physician investigators in the VCKD who are undertaking cutting edge basic and clinical and translational research aimed at treating and curing kidney disease.